BALDR: A Web-based platform for informed comparison and prioritization of biomarker candidates for type 2 diabetes mellitus

Author:

Lundgaard Agnete T.ORCID,Burdet Frédéric,Siggaard Troels,Westergaard David,Vagiaki DanaiORCID,Cantwell Lisa,Röder Timo,Vistisen DorteORCID,Sparsø Thomas,Giordano Giuseppe N.,Ibberson Mark,Banasik KarinaORCID,Brunak SørenORCID

Abstract

Novel biomarkers are key to addressing the ongoing pandemic of type 2 diabetes mellitus. While new technologies have improved the potential of identifying such biomarkers, at the same time there is an increasing need for informed prioritization to ensure efficient downstream verification. We have built BALDR, an automated pipeline for biomarker comparison and prioritization in the context of diabetes. BALDR includes protein, gene, and disease data from major public repositories, text-mining data, and human and mouse experimental data from the IMI2 RHAPSODY consortium. These data are provided as easy-to-read figures and tables enabling direct comparison of up to 20 biomarker candidates for diabetes through the public website https://baldr.cpr.ku.dk.

Funder

Innovative Medicines Initiative

Horizon 2020

European Federation of Pharmaceutical Industries and Associations

Staatssekretariat für Bildung, Forschung und Innovation

Novo Nordisk Fonden

Bayer

Sanofi

Novo Nordisk

Boehringer Ingelheim

Publisher

Public Library of Science (PLoS)

Subject

Computational Theory and Mathematics,Cellular and Molecular Neuroscience,Genetics,Molecular Biology,Ecology,Modeling and Simulation,Ecology, Evolution, Behavior and Systematics

Reference41 articles.

1. DRPPM-EASY: A Web-Based Framework for Integrative Analysis of Multi-Omics Cancer Datasets;A Obermayer;Biology,2022

2. POMAShiny: A user-friendly web-based workflow for metabolomics and proteomics data analysis;P Castellano-Escuder;PLoS Comput Biol,2021

3. From heterogeneous healthcare data to disease-specific biomarker networks: A hierarchical Bayesian network approach;AK Becker;PLoS Comput Biol,2021

4. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants;NCD Risk Factor Collaboration;Lancet,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3